Drug interactions can significantly affect the levels and toxicity of pyrazinoic acid. Concomitant use of drugs that induce or inhibit liver enzymes, such as cytochrome P450 isoenzymes, can alter the metabolism and clearance of pyrazinamide and its metabolite. These interactions can either increase the risk of toxicity or reduce therapeutic efficacy, necessitating careful consideration of patient medication history during treatment planning.
